Insider Transactions in Q3 2021 at Phreesia, Inc. (PHR)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 01
2021
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
4,978
-1.15%
|
$348,460
$70.56 P/Share
|
|
Sep 01
2021
|
David Linetsky SVP, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
4,978
+3.31%
|
$19,912
$4.71 P/Share
|
|
Aug 31
2021
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
474
-0.34%
|
$33,654
$71.84 P/Share
|
|
Aug 31
2021
|
David Linetsky SVP, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
474
+0.34%
|
$1,896
$4.71 P/Share
|
|
Aug 30
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
54,672
-1.41%
|
$3,881,712
$71.71 P/Share
|
|
Aug 30
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
54,672
+2.08%
|
$328,032
$6.37 P/Share
|
|
Aug 27
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
57,556
-1.11%
|
$4,086,476
$71.92 P/Share
|
|
Aug 27
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
57,556
+4.22%
|
$230,224
$4.71 P/Share
|
|
Aug 27
2021
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
21,455
-3.45%
|
$1,523,305
$71.89 P/Share
|
|
Aug 27
2021
|
David Linetsky SVP, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
21,455
+11.71%
|
$42,910
$2.55 P/Share
|
|
Aug 26
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
800
-0.06%
|
$56,000
$70.05 P/Share
|
|
Aug 26
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
800
+0.06%
|
$3,200
$4.71 P/Share
|
|
Aug 26
2021
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
800
-0.57%
|
$56,000
$70.07 P/Share
|
|
Aug 26
2021
|
David Linetsky SVP, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
800
+0.56%
|
$1,600
$2.55 P/Share
|
|
Aug 25
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
600
-0.05%
|
$42,000
$70.03 P/Share
|
|
Aug 25
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+0.05%
|
$2,400
$4.71 P/Share
|
|
Aug 25
2021
|
David Linetsky SVP, Life Sciences |
SELL
Open market or private sale
|
Direct |
500
-0.35%
|
$35,000
$70.04 P/Share
|
|
Aug 25
2021
|
David Linetsky SVP, Life Sciences |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+0.35%
|
$1,000
$2.55 P/Share
|
|
Aug 25
2021
|
Allison C Hoffman General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
2,082
-2.48%
|
$143,658
$69.05 P/Share
|
|
Aug 24
2021
|
Allison C Hoffman General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,577
-2.98%
|
$177,813
$69.54 P/Share
|
|
Aug 06
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,660
-0.13%
|
$116,200
$70.53 P/Share
|
|
Aug 06
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,660
+0.13%
|
$6,640
$4.71 P/Share
|
|
Aug 05
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
28,120
-2.2%
|
$1,968,400
$70.27 P/Share
|
|
Aug 05
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,120
+2.16%
|
$112,480
$4.71 P/Share
|
|
Aug 05
2021
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
8,236
-4.7%
|
$576,520
$70.13 P/Share
|
|
Aug 05
2021
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,236
+4.49%
|
$16,472
$2.03 P/Share
|
|
Aug 05
2021
|
Amy Beth Van Duyn SVP, Human Resources |
SELL
Open market or private sale
|
Direct |
5,273
-3.14%
|
$363,837
$69.72 P/Share
|
|
Jul 30
2021
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
128
+0.45%
|
$8,704
$68.35 P/Share
|
|
Jul 30
2021
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
128
+0.89%
|
$8,704
$68.35 P/Share
|
|
Jul 30
2021
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
10
-0.01%
|
$700
$70.0 P/Share
|
|
Jul 30
2021
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10
+0.01%
|
$20
$2.03 P/Share
|
|
Jul 30
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
102
-0.01%
|
$7,140
$70.0 P/Share
|
|
Jul 30
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
102
+0.01%
|
$408
$4.71 P/Share
|
|
Jul 29
2021
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
1,754
-1.04%
|
$122,780
$70.02 P/Share
|
|
Jul 29
2021
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,754
+1.03%
|
$3,508
$2.03 P/Share
|
|
Jul 29
2021
|
Chaim Indig Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,779
-0.54%
|
$474,530
$70.03 P/Share
|
|
Jul 29
2021
|
Chaim Indig Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,779
+0.27%
|
$20,337
$3.37 P/Share
|
|
Jul 21
2021
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
2,500
-1.47%
|
$162,500
$65.15 P/Share
|
|
Jul 21
2021
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+1.45%
|
$5,000
$2.03 P/Share
|
|
Jul 20
2021
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
7,500
-4.3%
|
$487,500
$65.08 P/Share
|
|
Jul 20
2021
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.12%
|
$15,000
$2.03 P/Share
|
|
Jul 16
2021
|
Michael Weintraub Director |
SELL
Open market or private sale
|
Direct |
20,000
-5.48%
|
$1,260,000
$63.89 P/Share
|
|
Jul 16
2021
|
Michael Weintraub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.66%
|
$40,000
$2.03 P/Share
|
|
Jul 08
2021
|
Edward L Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,605
+8.38%
|
-
|
|
Jul 08
2021
|
Lainie Goldstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,605
+15.63%
|
-
|
|
Jul 08
2021
|
Gillian Munson Director |
SELL
Open market or private sale
|
Direct |
3,055
-6.83%
|
$192,465
$63.46 P/Share
|
|
Jul 08
2021
|
Gillian Munson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,605
+10.18%
|
-
|
|
Jul 08
2021
|
Cheryl Pegus |
BUY
Grant, award, or other acquisition
|
Direct |
2,605
+14.13%
|
-
|
|
Jul 08
2021
|
Michael Weintraub Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,605
+1.54%
|
-
|
|
Jul 08
2021
|
Mark Douglas Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,605
+23.01%
|
-
|